Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pBI-11, TA-HPV, and Pembrolizumab in Advanced HPV+ Oropharyngeal Cancer
NCT05799144Phase 2Recruiting
- Start
- Jul 2023
- Primary completion
- Sep 2027
- Modality
- Prophylactic Vaccines, Oncolytic Viruses, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pBI-11, TA-HPV in oropharyngeal cancer. Started Jul 2023; status: recruiting.
02
Drugs
pBI-11TA-HPV
03
Conditions
oropharyngeal cancer
Beyond the preview
Go deeper on NCT05799144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05799144.